Abstract
Biomolecular computation and synthetic biology are the main disciplines in the design and implementation of biological computing devices. This article examines some of the key works concerning this type of logical devices processing biological information. Their design and construction follow two main approaches. The first approach builds computing devices based on the properties of nucleic acids, whereas the second approach focuses on genetic regulatory networks. Examples of the nucleic acid based approach are DNA self-assembly, DNA automata based on restriction enzymes or deoxyribozymes and logic circuits based on DNA strand displacement. Examples of the use of genetic networks are NOT, AND and OR logic gates, a genetic toggle switch that works like a biological memory unit, and several genetic oscillators that work as biological clocks.
Keywords: DNA computing, biomolecular computation, synthetic biology, genetic circuit, strand displacement, molecular automata, nucleic acids, enzymes, DNA molecules, Genetic Oscillators
Current Bioinformatics
Title: Biomolecular Computers
Volume: 6 Issue: 2
Author(s): Inaki Sainz de Murieta, Jesus M. Miro-Bueno and Alfonso Rodriguez-Paton
Affiliation:
Keywords: DNA computing, biomolecular computation, synthetic biology, genetic circuit, strand displacement, molecular automata, nucleic acids, enzymes, DNA molecules, Genetic Oscillators
Abstract: Biomolecular computation and synthetic biology are the main disciplines in the design and implementation of biological computing devices. This article examines some of the key works concerning this type of logical devices processing biological information. Their design and construction follow two main approaches. The first approach builds computing devices based on the properties of nucleic acids, whereas the second approach focuses on genetic regulatory networks. Examples of the nucleic acid based approach are DNA self-assembly, DNA automata based on restriction enzymes or deoxyribozymes and logic circuits based on DNA strand displacement. Examples of the use of genetic networks are NOT, AND and OR logic gates, a genetic toggle switch that works like a biological memory unit, and several genetic oscillators that work as biological clocks.
Export Options
About this article
Cite this article as:
Sainz de Murieta Inaki, M. Miro-Bueno Jesus and Rodriguez-Paton Alfonso, Biomolecular Computers, Current Bioinformatics 2011; 6 (2) . https://dx.doi.org/10.2174/1574893611106020173
DOI https://dx.doi.org/10.2174/1574893611106020173 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nonstandard Drugs and Feasible New Interventions for Autoimmune Hepatitis: Part I
Inflammation & Allergy - Drug Targets (Discontinued) Advanced QSAR Methods Evaluated Polycyclic Aromatic Compounds Duality as Drugs and Inductors in Psychiatric Disorders
Current Organic Chemistry Aligning Animal Models of Clinical Germinal Matrix Hemorrhage, From Basic Correlation to Therapeutic Approach
Current Drug Targets Hijacking the Hedgehog Pathway in Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Gene Expression Signatures in Primary Immunodeficiencies: The Experience from Human Disease and Mouse Models
Current Molecular Medicine The Delivery of Personalised, Precision Medicines <i>via</i> Synthetic Proteins
Drug Delivery Letters Disruption of Circadian Rhythms and Delirium, Sleep Impairment and Sepsis in Critically ill Patients. Potential Therapeutic Implications for Increased Light-Dark Contrast and Melatonin Therapy in an ICU Environment
Current Pharmaceutical Design Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery
Current Drug Research Reviews Opportunities for Nano-Formulations in Type 2 Diabetes Mellitus Treatments
Current Pharmaceutical Biotechnology Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio as Biomarkers for Cardiovascular Surgery Procedures: A Literature Review
Reviews on Recent Clinical Trials Stem Cells, Cancer, Liver, and Liver Cancer Stem Cells: Finding a Way Out of the Labyrinth...
Current Cancer Drug Targets Zinc Complexes Developed as Metallopharmaceutics for Treating Diabetes Mellitus based on the Bio-Medicinal Inorganic Chemistry
Current Topics in Medicinal Chemistry Emerging Treatments in Acute Lymphoblastic Leukemia
Current Cancer Drug Targets The Role of Androgen Under Normal and Pathological Conditions in Sebaceous Glands: The Possibility of Target Therapy
Current Molecular Pharmacology Some Developments Regarding Functional Food Products (Functional Foods)
Current Nutrition & Food Science Viral Vectors in Cancer Immunotherapy: Which Vector for Which Strategy?
Current Gene Therapy In Vivo Bio-imaging Using Chlorotoxin-based Conjugates
Current Pharmaceutical Design Targeting CREB for Cancer Therapy: Friend or Foe
Current Cancer Drug Targets Epigenetic Effects of Cadmium in Cancer: Focus on Melanoma
Current Genomics Cannabinoid Receptor Activation and the Endocannabinoid System in the Gastrointestinal Tract
Current Neuropharmacology